New!
Portfolio
Login
/
Sign Up
Search
Industries
Technology
Energy
Media
Finance
Green Issues
China
All Concepts
Metals
Energy
Meats
Grains
Softs
ETFs
Indices
Currencies
Geographies
Exchanges
Rates
How To Invest
Personal Finance
Options 101
Definitions
close
close
close
close
Send us Feedback
Omrix Biopharmaceuticals (OMRI)
SUMMARY
BULLS
BEARS
TOPICS
DATA CENTRAL
STOCK CHART
SEC FILINGS
BALANCE
INCOME
CASH FLOW
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
Income Statement (USD)
Annual
|
Quarterly
QUARTER ENDING
30-SEP
2007
31-DEC
2007
31-MAR
2008
30-JUN
2008
30-SEP
2008
Total Revenue
15.8M
20.6M
17.7M
19.2M
21.3M
Gross Profit
6.58M
8.60M
8.03M
8.40M
9.11M
Research & Development
916K
1.38M
1.99M
1.56M
1.58M
SG&A
3.02M
5.03M
4.83M
4.24M
3.96M
Amortization & Deprec
325K
429K
387K
414K
43.0K
Other Expenses
-1.40M
-992K
-1.46M
-885K
-323K
Total Operating Expenses
2.86M
5.85M
5.74M
5.33M
5.26M
Operating Income
2.32M
1.76M
833K
2.19M
3.52M
Other Income
0
758K
0
215K
0
EBIT
3.71M
3.51M
2.29M
3.29M
3.85M
Minority Interest
0
0
0
0
0
Interest Expense
0
206K
0
0
0
Income Before Taxes
3.71M
3.31M
2.29M
3.29M
3.85M
Income Taxes
0
0
200K
300K
250K
Net Income from Continuing Ops
3.71M
3.31M
2.09M
2.99M
3.60M
Income - Discontinued Ops
0
0
0
0
0
Extraordinary Items
0
0
0
0
0
Effect of Accounting Changes
0
0
0
0
0
Other Items
0
0
0
0
0
Net Income
3.71M
3.31M
2.09M
2.99M
3.60M
Preferred Dividends
0
0
0
0
0
Net Income to Common
3.71M
3.31M
2.09M
2.99M
3.60M
Add Metric
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
Bet you've never seen portfolio analytics like these.
Introducing
SigFig
— from the creators of
Take Tour